Prescription weight loss drugs have become so popular in the United States that suppliers have struggled to keep up.

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

We’re firmly in the “buyer beware” era of obesity drugs. And unfortunately, it seems like we’re going to be stuck here for a ...

So what are Ozempic burps, exactly? Read on for the full scoop from a medical expert , plus some sage advice on how best to ...

Due to increased demand, price hikes and long-term shortages, obtaining prescriptions for weight loss drugs such as ...

U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...

In late June, generic drug maker Teva Pharmaceuticals launched a generic version of Victoza, a blockbuster diabetes drug, in ...

There is soaring demand for weight-loss drugs in the GLP-1 class, and the company will now sell it to certain professions for ...

Senator Sanders (I-Vt.) says CEOs of generic drugmakers are willing to sell Novo Nordisk’s (NVO) blockbuster obesity medicine ...

Americans are paying more than $900 a month for popular weight-loss drugs Ozempic and Wegovy, but drugmakers want to sell ...

chair of the Senate health committee, on Tuesday announced that generic versions of Novo Nordisk’s blockbuster ... high ...

Senator Bernie Sanders reveals that generic drug manufacturers can sell semaglutide, the generic of Ozempic & Wegovy, for less than $100 a month.